State Street’s Sonoma Pharmaceuticals SNOA Stock Holding History

State Street’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,216	Closed	-$5.16K	–	4332
2024 Q2	$5.16K	Hold	1,216	–	–	﹤0.01%	4351
2024 Q1	$4.04K	Hold	1,216	–	–	﹤0.01%	4357
2023 Q4	$4.39K	Hold	1,216	–	–	﹤0.01%	4426
2023 Q3	$18.8K	Hold	1,216	–	–	﹤0.01%	4450
2023 Q2	$26.5K	Buy	+1,216	New	+$25K	﹤0.01%	4554

Other funds holding SNOA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

State Street's SNOA Position: Q3 2024 in Review

State Street sold out of Sonoma Pharmaceuticals (SNOA) in Q3 2024, closing a stake of 1,216 shares — an estimated $5.16K sold.

State Street first reported a position in SNOA in Q2 2023 and held it in 5 quarters. The position peaked at $26.5K in Q2 2023. 14 funds tracked by Wall St. Rank hold SNOA as of Q3 2024.

State Street reported no remaining Sonoma Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
State Street sold 1,216 Sonoma Pharmaceuticals shares in Q3 2024, an estimated $5.16K.
State Street first reported a position in Sonoma Pharmaceuticals in Q2 2023 and held it in 5 quarters.
State Street's Sonoma Pharmaceuticals position peaked at $26.5K in Q2 2023.
14 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q3 2024.

Based on State Street's 13F filing for Q3 2024, filed 14 Nov 2024.